Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for several indications: type 2 diabetes mellitus, chronic weight management, and more recently, to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either overweight or obesity
Thus, when you try to lose weight by cutting calories, you are essentially fighting your own biology, and without assistance, biology usually wins
Over a six-month treatment period, the total cost projection for tirzepatide through Willow averages approximately $2,719, or roughly $453 per month when accounting for dose escalation
In adolescents, androgen excess shows as severe acne and hirsutism
BevNET and Nosh senior reporter Brad Avery joins the show as the hosts unpack Unilevers acquisition of fast-growing functional gummy brand Grns, and why strong repeat purchase and DTC momentum can drive outsized valuations even without broad retail distribution